Similar articles

• Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.

  Yuki N. Yuki N. J Infect Dis. 1997 Dec;176 Suppl 2:S150-3. doi: 10.1086/513800. J Infect Dis. 1997. PMID: 9396700 Review.
• Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes.

  Koga M, Yuki N, Takahashi M, Saito K, Hirata K. Koga M, et al. J Neuroimmunol. 1998 Jan;81(1-2):138-43. doi: 10.1016/s0165-5728(97)00168-9. J Neuroimmunol. 1998. PMID: 9521615
• Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections.

  Hao Q, Saida T, Kuroki S, Nishimura M, Nukina M, Obayashi H, Saida K. Hao Q, et al. J Neuroimmunol. 1998 Jan;81(1-2):116-26. doi: 10.1016/s0165-5728(97)00166-5. J Neuroimmunol. 1998. PMID: 9521613
• GM1 antibody in Guillain-Barre syndrome after Campylobacter jejuni infection.

  Tang J, Yuan J, Hao H. Tang J, et al. Chin Med J (Engl). 1995 Apr;108(4):262-4. Chin Med J (Engl). 1995. PMID: 7789212
• [Guillain-Barré syndrome of axonal type, Campylobacter jejuni infection and anti-ganglioside GM1 antibodies].

  Attarian S, Bonnefoi-Kyriacou B, Gayraud D, Mignard P, Boucraut J, Pouget J, Viallet F. Attarian S, et al. Rev Neurol (Paris). 1997 Apr;153(3):205-8. Rev Neurol (Paris). 1997. PMID: 9296136 Review. French.